NP461524.RAzZApF97jEs-triEcouIZda OfBX daixc d p Q804
has assertion: NP461524.RAzZApF97jEs-triEcouIZda OfBX daixc d p Q804130 assertion
has provenance: NP461524.RAzZApF97jEs-triEcouIZda OfBX daixc d p Q804130 provenance
has publication info: NP461524.RAzZApF97jEs-triEcouIZda OfBX daixc d p Q804130 publicationInfo
type: Nanopublication
created: 2016-05-13T12:45:14+02:00
rights: http://opendatacommons.org/licenses/odbl/1.0/
rights holder: IBIGroup
subject: SIO_000983
used data: disgenetv3.0rdf
authored by: http://orcid.org/0000-0001-5999-6269
authored by: http://orcid.org/0000-0002-7534-7661
authored by: 0000-0002-9383-528X
authored by: http://orcid.org/0000-0003-0169-8159
authored by: http://orcid.org/0000-0003-1244-7654
created by: http://orcid.org/0000-0003-0169-8159
version: v4.0.0.0

NP461524.RAzZApF97jEs-triEcouIZda OfBX daixc d p Q804130 assertion
type: Assertion
description: [However, the emerging role of TF in the pathogenesis of diseases such as sepsis, atherosclerosis, certain cancers and diseases characterized by pathological fibrin deposition such as disseminated intravascular coagulation and thrombosis, has directed attention to the development of novel inhibitors of tissue factor for use as antithrombotic drugs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
evidence: DisGeNET evidence - LITERATURE
SIO_000772: http://identifiers.org/pubmed/15389118
was generated by: ECO_0000203

befree-2016
imported on: 2016-02-19

DisGeNET evidence - LITERATURE
type: ECO_0000212
comment: Gene-disease associations inferred from text-mining the literature.

disgenetv3.0rdf
version: v4.0.0